v3.24.1.u1
Equity
 3 Months Ended
Mar. 28, 2024
Stockholders' Equity Note [Abstract]  
Equity Equity
 
Earnings per Share Calculation
 
Basic net income per share is computed using the weighted-average number of outstanding shares of Common Stock during the measurement period. Diluted net income per share is computed using the weighted-average number of outstanding shares of Common Stock and, when dilutive, potential outstanding shares of Common Stock during the measurement period. Diluted earnings per share includes any dilutive impact of service-based restricted stock units, director restricted stock units, restricted stock awards, and performance-based restricted stock units.

The Company accounts for treasury stock under the cost method and includes treasury stock as a component of stockholders’ equity. As of March 28, 2024, no treasury shares have been reissued or retired.

The total authorization amount remaining under the current share repurchase program is approximately $925.0. During the three-month period ended March 28, 2024, the Company did not repurchase any shares of its Common Stock under this share repurchase program. Share repurchases are currently on hold. The Credit Agreement imposes restrictions on the Company’s ability to repurchase shares.

The following table sets forth the computation of basic and diluted earnings per share:

For the Three Months Ended
March 28, 2024March 30, 2023
IncomeSharesPer Share
Amount		IncomeSharesPer Share
Amount
Basic EPS
Loss available to common stockholders$(616.7)116.2 $(5.31)$(281.2)104.9 $(2.68)
Income allocated to participating securities— — — — 
Net loss$(616.7)$(281.2)
Diluted potential common shares— — 
Diluted EPS
Net loss$(616.7)116.2 $(5.31)$(281.2)104.9 $(2.68)

Included in the outstanding Common Stock were 0.0 million and 0.1 million of issued but unvested shares at March 28, 2024 and March 30, 2023, respectively, which are excluded from the basic Earnings Per Share (“EPS”) calculation.

Shares of Common Stock of 9.6 million were excluded from diluted EPS as a result of incurring a net loss for the three months ended March 28, 2024, as the effect would have been antidilutive. Additionally, diluted EPS for the three months ended March 28, 2024 excludes 0.2 million shares that may be dilutive shares of Common Stock in the future but were not included in the computation of diluted EPS because the effect was either antidilutive or the performance condition was not met.

Shares of Common Stock of 0.9 million were excluded from diluted EPS as a result of incurring a net loss for the three months ended March 30, 2023, as the effect would have been antidilutive. Additionally, diluted EPS for the three months ended March 30, 2023 excludes 0.2 million shares that may be dilutive shares of Common Stock in the future but were not included in the computation of diluted EPS because the effect was either antidilutive or the performance condition was not met.
Accumulated Other Comprehensive Loss
 
Accumulated Other Comprehensive Loss is summarized by component as follows:
As ofAs of
 March 28, 2024December 31, 2023
Pension$(18.4)$(18.7)
SERP/Retiree medical6.7 6.8 
Derivatives - foreign currency hedge— 2.2 
Foreign currency impact on long-term intercompany loan(14.9)(14.6)
Currency translation adjustment(70.6)(65.3)
Total accumulated other comprehensive loss$(97.2)$(89.6)
 
Amortization or settlement cost recognition of the pension plans’ net gain/(loss) reclassified from accumulated other comprehensive loss and realized into cost of sales and selling, general and administrative on the Condensed Consolidated Statements of Operations was $0.1 and ($64.0) for the three months ended March 28, 2024 and March 30, 2023, respectively.